C-REACTIVE PROTEIN MODULATES HUMAN LUNG FIBROBLAST MIGRATION

REFERENCES

• Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448–454
   PubMed Web of Science ®Google Scholar
• Griselli M, Herbert J, Hutchinson W L, Taylor K M, Sohail M, Krausz T, Pepys M B. C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. J Exp Med 1999; 190: 1733–1740
   PubMed Web of Science ®Google Scholar
• Kew R R, Hyers T M, Webster R O. Human C-reactive protein inhibits neutrophil chemotaxis in vitro: possible implications for the adult respiratory distress syndrome. J Lab Clin Med 1990; 115: 339–345
   PubMedGoogle Scholar
• Heuertz R M, Webster R O. Role of C-reactive protein in acute lung injury. Mol Med Today 1997; 3: 539–545
   PubMedGoogle Scholar
• Zhong W, Zen Q, Tebo J, Schlottmann K, Coggeshall M, Mortensen R F. Effect of human C-reactive protein on chemokine and chemotactic factor-induced neutrophil chemotaxis and signaling. J Immunol 1998; 161: 2533–2540
   PubMed Web of Science ®Google Scholar
• Heuertz R M, Tricomi S M, Ezekiel U R, Webster R O. C-reactive protein inhibits chemotactic peptide-induced p38 mitogen-activated protein kinase activity and human neutrophil movement. J Biol Chem 1999; 274: 17968–17974
   PubMed Web of Science ®Google Scholar
• Verma S, Wang C H, Li S H, Dumont A S, Fedak P W, Badiwala M V, Dhillon B, Weisel R D, Li R K, Mickle D A, Stewart D J. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 2002; 106: 913–919
   PubMed Web of Science ®Google Scholar
• Wang C H, Li S H, Weisel R D, Fedak P W, Dumont A S, Szmitko P, Li R K, Mickle D A, Verma S. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation 2003; 107: 1783–1790
   PubMed Web of Science ®Google Scholar
• Gould J M, Weiser J N. Expression of C-reactive protein in the human respiratory tract. Infect Immun 2001; 69: 1747–1754
   PubMed Web of Science ®Google Scholar
• Arase Y, Ikeda K, Tsubota A, Saitoh S, Suzuki Y, Kobayashi M, Suzuki F, Someya T, Akuta N, Hosaka T, Kobayashi M, Kumada H. Usefulness of serum KL-6 for early diagnosis of idiopathic pulmonary fibrosis in patients with hepatitis C virus. Hepatol Res 2003; 27: 89–94
   PubMed Web of Science ®Google Scholar
• Boyden S. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leukocytes. J Exp Med 1962; 115: 453–466
   PubMed Web of Science ®Google Scholar
• Kohyama T, Liu X D, Wen F Q, Kim H J, Takizawa H, Rennard S I. Prostaglandin D2 inhibits fibroblast migration. Eur Respir J 2002; 19: 684–689
   PubMed Web of Science ®Google Scholar
• Yamauchi Y, Okazaki H, Desaki M, Kohyama T, Kawasaki S, Yamamoto K, Takizawa H. Methotrexate induces interleukin-8 production by human bronchial and alveolar epithelial cells. Clin Sci (Lond) 2004; 106: 619–625
   PubMed Web of Science ®Google Scholar
• Liu C, Wang S, Deb A, Nath K A, Katusic Z S, McConnell J P, Caplice N M. Proapoptotic, antimigratory, antiproliferative, and antiangiogenic effects of commercial C-reactive protein on various human endothelial cell types in vitro: implications of contaminating presence of sodium azide in commercial preparation. Circ Res 2005; 97: 135–143
   PubMed Web of Science ®Google Scholar
• VanUffelen B E, Van der Zee J, de Koster B M, Van Steveninck J, Elferink J G. Sodium azide enhances neutrophil migration and exocytosis: involvement of nitric oxide, cyclic GMP and calcium. Life Sci 1998; 63: 645–657
   PubMed Web of Science ®Google Scholar
• Kohyama T, Liu X, Wen F Q, Kim H J, Takizawa H, Rennard S I. Potentiation of human lung fibroblast chemotaxis by the thromboxane A(2) analog U-46619. J Lab Clin Med 2002; 139: 43–49
   PubMedGoogle Scholar
• Parra E R, David Y R, da Costa L R, Ab'Saber A, Sousa R, Kairalla R A, de Carvalho C R, Filho M T, Capelozzi V L. Heterogeneous remodeling of lung vessels in idiopathic pulmonary fibrosis. Lung 2005; 183: 291–300
   PubMed Web of Science ®Google Scholar
• Chung K F. The role of airway smooth muscle in the pathogenesis of airway wall remodeling in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2: 347–354
   PubMedGoogle Scholar
• Hogg J C, Chu F, Utokaparch S, Woods R, Elliott W M, Buzatu L, Cherniack R M, Rogers R M, Sciurba F C, Coxson H O, Pare P D. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 2645–2653
   PubMed Web of Science ®Google Scholar
• Lavigne M C, Thakker P, Gunn J, Wong A, Miyashiro J S, Wasserman A M, Wei S Q, Pelker J W, Kobayashi M, Eppihimer M J. Human bronchial epithelial cells express and secrete MMP-12. Biochem Biophys Res Commun 2004; 324: 534–546
   PubMed Web of Science ®Google Scholar
• Karagiannidis C, Hense G, Martin C, Epstein M, Ruckert B, Mantel P Y, Menz G, Uhlig S, Blaser K, Schmidt-Weber C B. Activin A is an acute allergen-responsive cytokine and provides a link to TGF-beta-mediated airway remodeling in asthma. J Allergy Clin Immunol 2006; 117: 111–118
   PubMed Web of Science ®Google Scholar
• Sun H, Koike T, Ichikawa T, Hatakeyama K, Shiomi M, Zhang B, Kitajima S, Morimoto M, Watanabe T, Asada Y, Chen Y E, Fan J. C-reactive protein in atherosclerotic lesions: its origin and pathophysiological significance. Am J Pathol 2005; 167: 1139–1148
   PubMed Web of Science ®Google Scholar
• Danesh J, Wheeler J G, Hirschfield G M, Eda S, Eiriksdottir G, Rumley A, Lowe G D, Pepys M B, Gudnason V. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004; 350: 1387–1397
   PubMed Web of Science ®Google Scholar
• Cermak J, Key N S, Bach R R, Balla J, Jacob H S, Vercellotti G M. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993; 82: 513–520
   PubMed Web of Science ®Google Scholar
• Kawamoto M, Matsunami T, Ertl R F, Fukuda Y, Ogawa M, Spurzem J R, Yamanaka N, Rennard S I. Selective migration of α -smooth muscle actin-positive myofibroblasts toward fibronectin in the Boyden's blindwell chamber. Clin Sci 1997; 93: 355–362
   PubMed Web of Science ®Google Scholar
• Mattoli S, Colotta F, Fincato G, Mezzetti M, Mantovani A, Patalano F, Fasoli A. Time course of IL1 and IL6 synthesis and release in human bronchial epithelial cell cultures exposed to toluene diisocyanate. J Cell Physiol 1991; 149: 260–268
   PubMed Web of Science ®Google Scholar
• Rousseau S, Dolado I, Beardmore V, Shpiro N, Marquez R, Nebreda A R, Arthur J S, Case L M, Tessier-Lavigne M, Gaestel M, Cuenda A, Cohen P. CXCL12 and C5a trigger cell migration via a PAK1/2-p38alpha MAPK-MAPKAP-K2-HSP27 pathway. Cell Signal 2006; 18: 1897–1905
   PubMed Web of Science ®Google Scholar
• Raia V, Maiuri L, Ciacci C, Ricciardelli I, Vacca L, Auricchio S, Cimmino M, Cavaliere M, Nardone M, Cesaro A, Malcolm J, Quaratino S, Londei M. Inhibition of p38 mitogen activated protein kinase controls airway inflammation in cystic fibrosis. Thorax 2005; 60: 773–780
   Google Scholar
• Kohyama T, Ertl R F, Valenti V, Spurzem J, Kawamoto M, Nakamura Y, Veys T, Allegra L, Romberger D, Rennard S I. Prostaglandin E(2) inhibits fibroblast chemotaxis. Am J Physiol Lung Cell Mol Physiol 2001; 281: L1257–L1263
   PubMed Web of Science ®Google Scholar
• Kohyama T, Liu X, Kim H J, Kobayashi T, Ertl R F, Wen F Q, Takizawa H, Rennard S I. Prostacyclin analogs inhibit fibroblast migration. Am J Physiol Lung Cell Mol Physiol 2002; 283: L428–L432
   PubMed Web of Science ®Google Scholar
• Taylor K E, Giddings J C, van den Berg C W. C-reactive protein-induced in vitro endothelial cell activation is an artefact caused by azide and lipopolysaccharide. Arterioscler Thromb Vasc Biol 2005; 25: 1225–1230
   PubMed Web of Science ®Google Scholar